Olympus Corporation of the Americas Olympus Airway Mobilescope, Models MAF-GM & MAF-TM. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Olympus Airway Mobilescope, Models MAF-GM & MAF-TM.
Brand
Olympus Corporation of the Americas
Lot Codes / Batch Numbers
UDI-DI: 04953170340369, 04953170288661, & 04953170288630, All Serial Numbers.
Products Sold
UDI-DI: 04953170340369, 04953170288661, & 04953170288630; All Serial Numbers.
Olympus Corporation of the Americas is recalling Olympus Airway Mobilescope, Models MAF-GM & MAF-TM. due to Complaint of endoscope model becoming lodged in the endotracheal tube connector due to diameter being too large.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Complaint of endoscope model becoming lodged in the endotracheal tube connector due to diameter being too large.
Recommended Action
Per FDA guidance
Consignees were mailed an Urgent Medical Device Correction notification dated 7/27/2023 via UPS. The notification asks that consignees inspect their inventory for recalled devices and check clinical areas to see if any remain in use. Consignees are to ensure that all personnel, including clinical staff, are completely knowledgeable of this recall notification and addendum, which instructs users to slide the endotracheal tube along the entire length of the tracheal intubation scope insertion section to confirm compatibility before using on a patient. Consignees are asked to complete and return the provided response form to Sedgwick via email at Olympus7498@sedgwick.com or by fax at 866-552-4917. Any questions about the acknowledgement form may be directed by phone to 866-737-4762. If product has been further distributed, please forward the notification to those secondary consignees and maintain records of your documentation process. Consignees are to report any complaints to Olympus Technical Assistance Center at 1-800-848-9024 (Option 1) and FDA Medwatch. Any further questions are to be directed to Tara Safi by email at Tara.Safi@Olympus.com.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026